Viren Konde

Biotechnlogy Analyst, Biopharmaceuticals Industry

India

Current
  • Sr. Executive at Genova Biopharma
Past
  • Assistant Professor, Biotechnology Management at MTCON Institute of Management, Pune
  • Postdoctoral Research Scientist at University of Houston, USA
  • Postdoctoral Research Scientist at LCB-CNRS, Marseille, France
Education
  • Tamil Nadu Agricultural University
Connections
129 connections
Industry
Biotechnology
Websites

Viren Konde’s Summary

Dedicated quality professional with over ten years of experience in biotechnology. Primary interests include biotechnology industry analysis and markets review - Commercial, Scientific, Legal, and Regulatory Business Models of Biotechnology Companies. For more information, visit: http://biotechmanage.blogspot.com. Solid foundation in researching and evaluating biopharmaceutical industry analysis and data review.

Ph.D. in Biotechnology with specialization in Molecular Biology with more than a decade of research experience in molecular biology, cell biology, and bioinformatics. Proficient in cloning, mutagenesis, expression, immunology, and microscopy.

Presently working with a Biopharmaceuticals company. Has worked as senior researcher in India (CCMB, Hyderabad), and abroad (France and USA). Has also worked closely with senior management to provide scientific leadership and vision, and to maintain and increase the organization's reputation in the various communities.

Biotechnology Management Blog: Commercial, scientific and regulatory business models of biotechnology companies. (http://biotechmanage.blogspot.com).

Contributing author on http://www.istockanalyst.com and http://www.spagyrist.com: biotechnology industry analysis and biotech trends review.

Viren Konde’s Specialties:

Molecular Biologist, Biotechnology Analyst, Perl Programmer


Viren Konde’s Experience

  • Sr. Executive

    Genova Biopharma

    (Biotechnology industry)

    May 2008Present (1 year 7 months)

    Prophylactic and therapeutic vaccines research and development. Gennova is a spin-off of Emcure Pharmaceuticals Pvt. Ltd., working towards contract manufacturing of malaria vaccines and other recombinant proteins, as a facility set up in collaboration with Malaria PATH initiative. Also, actively pursuing the development of Active Pharmaceutical Ingredients (API) in specialized areas of cervical cancer vaccines. The function also includes overseeing technical support to Research & Development, and expanding the capability of the company into new niches.

    •Konde V. 2009. Biotechnology business models: An Indian Perspective. Journal of Commercial Biotechnology, doi: 10.1057/jcb.2008.52 (http://www.palgrave-journals.com/jcb/journal/vaop/ncurrent/abs/jcb200852a.html ). In press.

  • Assistant Professor, Biotechnology Management

    MTCON Institute of Management, Pune

    (Biotechnology industry)

    July 2006May 2008 (1 year 11 months)

    Taught lectures in various fields of biotechnology like molecular, cell biology, bioinformatics including the business of biotechnology like, the Drug Development Pipeline, Intellectual Property Rights in biotechnology, and the Biopharmaceutical Regulations in India and abroad, Bioethics, and its potential impact on the biopharmaceuticals industry, etc. with the primary focus on the best biotechnology management practices like Cost Management, Crisis Management, Quality Management, Strategic Alliance Management, and Intellectual Property Management.

    •Konde V. 2008. Biotechnology in India: Public-private Partnerships. Journal of Commercial Biotechnology, 14(1), 43–55. doi:10.1057/palgrave.jcb.3050079 (http://www.palgrave-journals.com/jcb/journal/v14/n1/abs/3050079a.html).

  • Postdoctoral Research Scientist

    University of Houston, USA

    (Biotechnology industry)

    June 2002June 2006 (4 years 1 month)

    Postdoctoral Research Associate with Dr. Joseph Eichberg, University of Houston, TX, USA, (2002-2006). Led a group in molecular neurobiology lab to develop real-time trafficking cell culture model using wild-type and mutated (phosphorylation, acylation, glycosylation) P0-GFP fusion constructs. Published the findings as the mutations of Myelin Protein Zero in the cytoplasmic domain interfere with its cellular trafficking in the peripheral nervous system leading to Charcot-Marie-Tooth disease.

    Constructed the cis-acting, adeno-associated viral vectors for gene delivery to study the regulation of circadian clock to light in mice with the Neurophysiology group of Dr. Michael Rea at the University of Houston in the collaboration with the Baylor College of Medicine, Houston, TX, USA.

    •Konde V. and Eichberg J. 2006. Myelin protein zero: Mutations in the cytoplasmic domain interfere with its cellular trafficking. Journal of Neuroscience Research, 83:957–964.

    •Eichberg J., Konde, V. B., Garga, V. and Rea, M.A. 2005. Trafficking of wild type and cytoplasmic domain-mutated myelin protein zero-GFP in living Schwann cells. Journal of Neurochemistry, 94 (Suppl. 1), 50.

  • Postdoctoral Research Scientist

    LCB-CNRS, Marseille, France

    (Biotechnology industry)

    July 2000May 2002 (1 year 11 months)

    Postdoctoral Research Scientist with C.N.R.S.-L.C.B., Marseille, France. Investigated the signaling events in the heterocyst-forming cyanobacterium Anabaena sp. strain PCC 7120. Published the results of the co-regulated 'C' and 'N' metabolic pathways using ketoglutarate transpoter from E. coli expressed under the control of a copper regulated plastocyanin `pet E` promoter in this nitrogen-fixing cyanobacteria.

    •Li JH, Laurent S., Konde V., Bedu S., Zhang C.C. 2003. An increase in the level of 2-oxoglutarate promotes heterocyst development in the cyanobacterium Anabaena sp. strain PCC 7120. Microbiology, 149: 3257-3263.

    •Konde V., Laurent S., Bedu S. and Zhang, C.C. 2001. Initial dissection of an activating signaling pathway of heterocyst differentiation in the cyanobacterium Anabaena PCC 7120. Paper: VIIth Cyanobacterial Workshop, A Signal Event, Virginia Tech, Pacific Grove, CA, USA. pp. 357-362.


Viren Konde’s Education

  • Tamil Nadu Agricultural University

    PhD , Biotechnology (Molecular Biology) , 19962000

    •Konde V.B. and Kannaiyan S. 2000. Identification of A. filiculoides x A. microphylla hybrid using protein and isozyme markers. J. Maharashtra Agric. Univ., 25 (2): 188-191.

    •Konde V.B. and Kannaiyan S. 2000. Azolla-Anabaena symbiosis: Establishment of the true symbiotic nature as detected by 15N studies. J. Maharashtra Agric. Univ., 25 (2): 184-187.

    •Konde V. B. and Kannaiyan S. 1998. Genetic diversity and phylogenetic analysis of the nitrogen-fixing water fern Azolla. Paper: Proceedings of the 39th Annual Conference, Association of Microbiologists of India, Mangalore, December 5-7, pp. 230-232.

    Activities and Societies:
    Senior Research Fellow during PhD at TNAU, Coimabtore. Studied the molecular phylogeny of algal symbionts of Azolla and free-living cyanobacterial cultures based on DNA amplification. Identified RAPD markers and isozyme loci for genetic variability across the species and accessions.

    •Konde V. B. and Kannaiyan S. 1999. Phylogenetic relationships of algal symbionts of Azolla and free-living cyanobacterial cultures based on DNA amplification. Nature Biotechnology, 17: 45.

Additional Information

Viren Konde’s Websites:


Public profile powered by: LinkedIn

Create a public profile: Sign In or Join Now

View Viren Konde’s full profile:

  • See who you and Viren Konde know in common
  • Get introduced to Viren Konde
  • Contact Viren Konde directly

View Full Profile